| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/25/2002 | WO2002056861A2 Syntactic deformable foam compositions and methods for making |
| 07/25/2002 | WO2002056860A1 Cleanser compositions |
| 07/25/2002 | WO2002056852A1 Cosmetics |
| 07/25/2002 | WO2002056843A2 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields |
| 07/25/2002 | WO2002056839A2 Pearlescent agent |
| 07/25/2002 | WO2002056829A2 Methods for preparing purified daptomycin |
| 07/25/2002 | WO2002056825A2 Composition and method to increase calcium levels in animals |
| 07/25/2002 | WO2002056808A1 Bioadhesive cell foam film of sustained-release delivery |
| 07/25/2002 | WO2002056796A1 Intravascular blood conditioning device and use thereof |
| 07/25/2002 | WO2002056709A1 Ingestible compositions containing an odoriferous oil |
| 07/25/2002 | WO2002056699A1 Coated chewing gum products containing an acid blocker |
| 07/25/2002 | WO2002045698A3 Silicone gel sheet for treatment of scar tissue |
| 07/25/2002 | WO2002045697A3 Composite material for counteracting edema |
| 07/25/2002 | WO2002039879A3 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 07/25/2002 | WO2002038077A3 L-histidine in ophthalmic solutions |
| 07/25/2002 | WO2002036591A3 Inhalative solution formulation containing a tiotropium salt |
| 07/25/2002 | WO2002036092A3 Mixture for treating skin |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002031092A3 Method for the inclusion of perfume oils in washing and cleaning agents or cosmetics |
| 07/25/2002 | WO2002030499A3 Medicament dispenser |
| 07/25/2002 | WO2002026282A3 Fluid delivery device with light activated energy source |
| 07/25/2002 | WO2002024152A3 Oil in glycerin emulsion |
| 07/25/2002 | WO2002018001A3 Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
| 07/25/2002 | WO2002017918A3 Sustained release formulations for growth hormone secretagogues |
| 07/25/2002 | WO2002017888A3 Controlled and sustained release properties of polyelectrolyte multilayer capsules |
| 07/25/2002 | WO2002015886A3 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2002015851A3 Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 07/25/2002 | WO2002009647A3 Biological component comprising artificial membrane |
| 07/25/2002 | WO2002000182A3 Structures and compositions increasing the stability of peroxide actives |
| 07/25/2002 | WO2001097872B1 Bioadhesive compositions and methods of preparation and use |
| 07/25/2002 | WO2001068079A3 Viscoelastics for use in middle ear surgery |
| 07/25/2002 | WO2001043698A9 Topical ointment |
| 07/25/2002 | WO2001032204A3 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 07/25/2002 | WO2001000654A9 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/25/2002 | WO2001000312A9 Spray drying process for preparing dry powders |
| 07/25/2002 | US20020099438 Irradiated stent coating |
| 07/25/2002 | US20020099361 Osmotic device having a preformed passageway that increases in size |
| 07/25/2002 | US20020099359 Flexible microchip devices for ophthalmic and other applications |
| 07/25/2002 | US20020099322 Adhering therapeutic tool |
| 07/25/2002 | US20020099321 Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same |
| 07/25/2002 | US20020099224 Hydrolysis of [R (R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099187 Process for preparing solubilization adjuvants from fusel oils and saccharides |
| 07/25/2002 | US20020099097 Pharmaceutical solutions of modafinil compounds |
| 07/25/2002 | US20020099067 Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 07/25/2002 | US20020099064 Analgesic combination of oxycodone and T-614 |
| 07/25/2002 | US20020099049 Analgesic combination of oxycodone and meloxicam |
| 07/25/2002 | US20020099043 Freeze-dried product and method for preparing the same |
| 07/25/2002 | US20020099023 Treating chronic obstructive pulmonary disease by administering an osmotically active compound to an airway surface of the subject in an amount effective to increase the volume of liquid on the airway surface. |
| 07/25/2002 | US20020099022 Anti-viral composition |
| 07/25/2002 | US20020099021 Carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, and unproductive cough |
| 07/25/2002 | US20020099018 Dissolving an oligopeptide, such as Bombesin-Antagonist, Protirelin, Somatostatin and Cetrorelix, in acetic acid; transferring the solution to water, and lyophilizing; treating female infertility; gonad protection |
| 07/25/2002 | US20020099003 Also improving vaginal muscle tone and tissue health, preventing vaginal atrophy, preventing vaginal pain during sexual intercourse, and alleviating vaginal itching and dryness; applying to the vagina and/or vulvar region |
| 07/25/2002 | US20020098579 Methods and compositions for poly-beta-1-4-N acetylglucosamine cell therapy system |
| 07/25/2002 | US20020098359 Method and apparatus for manufacture of magnetizable microparticles |
| 07/25/2002 | US20020098302 Hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film |
| 07/25/2002 | US20020098264 Rapid release of nicotine over the first few minutes of chewing added in absroption into the bloodstream by a buffer followed by slower release over a period of 30 minutes or more |
| 07/25/2002 | US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 07/25/2002 | US20020098241 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 07/25/2002 | US20020098240 Compositions comprising modafinil compounds |
| 07/25/2002 | US20020098239 Melting an animal or vegetable oil (hydrogenated soy oil) with drug/therapeautic agent, then cooling until hard; drug delivery |
| 07/25/2002 | US20020098238 Polylactides for use as implants for drugs such as octreotide (hydrophilic) or bromocriptine (lipophilic) |
| 07/25/2002 | US20020098237 Neurotoxin implant |
| 07/25/2002 | US20020098235 Comprises methacrylic acid-methyl methacrylate copolymer layers for drug delivery to gastrointestinal tract |
| 07/25/2002 | US20020098234 Comprises lytic enzyme for the infecting bacteria (Listeria, Salmonella, Escherichia coli, and Campylobacter) carried via suppository enemas, syrups, or enteric coated pills |
| 07/25/2002 | US20020098233 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 07/25/2002 | US20020098232 Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| 07/25/2002 | US20020098231 Antisense nucleotides; drug delivery; anticancer agents; gene expression inhibition |
| 07/25/2002 | US20020098229 Phospholipids capable of forming bilayers in aqueous solution, amphoteric surfactants, and nonionic surfactants, which allow water-insoluble polymer to be incorporated within for use on hair, skin, and eyelashes |
| 07/25/2002 | US20020098228 Patch comprising stiff elastic material which produces an audible click when depressed from its outer position to its inner position pierscing sealing film |
| 07/25/2002 | US20020098227 Process for manufacturing coated granules with masked taste and immediate release of the active principle |
| 07/25/2002 | US20020098225 Device for releasing with delayed effect an active substance, in particular veterinary |
| 07/25/2002 | US20020098224 Comprising histamine, its receptor analog, serotonin and its receptor analog in an opthalmic solution or gel for reducing irritation due to infection, allergies, pollutants and other irritants in a pharmaceutically acceptable carrier |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098215 Nanoemulsions comprising at least one amphiphilic lipid, at least one oil, and at least one nonionic polymer, and uses thereof |
| 07/25/2002 | US20020098208 Immersion of the aquatic animal (aquarium fish) in the antimicrobial solution containing EDTA and buffering agent; kits |
| 07/25/2002 | US20020098207 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 07/25/2002 | US20020098204 Veterinary vaccines |
| 07/25/2002 | US20020098203 Immnunologically active substance embedded in microparticles consisting of starch with amylopectin content greater than 85%; non-crosslinked |
| 07/25/2002 | US20020098198 Comprising therapeutic agent and solid foam formed from a protein and which is prepared by heating; dissolves rapidly in mouth, useful for children |
| 07/25/2002 | US20020098172 Improved absorption of Coenzyme Q10 into an intestinal tract and to maintain basal blood levels; 30-100 mg/day of coenzyme Q10, polyglycerol oleate and vitamin e |
| 07/25/2002 | US20020098161 Therapeutic polyanhydride compounds for drug delivery |
| 07/25/2002 | US20020098160 Use of borate-polyol complexes in ophthalmic compositions |
| 07/25/2002 | US20020098159 Surfactants and organic and/or inorganic acids |
| 07/25/2002 | US20020098157 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 07/25/2002 | US20020098154 Methods and apparatus for medicating the nasal sinuses |
| 07/25/2002 | US20020098112 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus |
| 07/25/2002 | DE10102005A1 Lustrous concentrate useful as an additive to give stable cosmetic or pharmaceutical preparations contains a wax and a nonionic and/or amphoteric surfactant |
| 07/25/2002 | DE10101529A1 A solution of cyclosporin in neutral oil, preferably medium chain triglyceride, is useful as an immunosuppressive agent |
| 07/25/2002 | CA2443895A1 Differential delivery of nitric oxide |
| 07/25/2002 | CA2443080A1 Lipid-based nitric oxide donors |
| 07/25/2002 | CA2435305A1 Extended release pharmaceutical compositions containing beta-lactam antibiotics |
| 07/25/2002 | CA2435287A1 Nucleic acid delivery formulations |
| 07/25/2002 | CA2435069A1 Treatment solution for taking care of wounds and dressing material to be used together with said treatment solution |
| 07/25/2002 | CA2434743A1 Stabilized brivudine topical formulations containing metal oxide pigments |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2434338A1 Pharmaceutical composition having reduced tendency for drug crystallization |
| 07/25/2002 | CA2434284A1 Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method |